PAKOLA STEVE 4
4 · REGENXBIO Inc. · Filed Aug 5, 2024
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
PAKOLA STEVE
Chief Medical Officer
Transactions
- Award
Common Stock
2024-08-01+58,386→ 165,578 total
Footnotes (1)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer.